Lyda Hill Philanthropies Backs Nonprofit Drugmaker Aiming to Lower Cancer Drug Costs

Lyda Hill Philanthropies is betting that one nonprofit pharmaceutical company can alleviate rising drug costs. Hill’s organization committed $3 million to California-based NP2, a pharmaceutical company founded in 2019 to manufacture lower-cost generic oncology drugs in the U.S. The two-year commitment, a mix of philanthropic support and milestone-based loan capital, is the largest gift in … Continued The post Lyda Hill Philanthropies Backs Nonprofit Drugmaker Aiming to Lower Cancer Drug Costs appeared first on D Magazine.